Trial Profile
Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab (ROTATE Trial)
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions
- Acronyms ROTATE
- 08 May 2013 New trial record